Cargando…

The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC

To analyze the relation between SNPs in DNA repair pathway-related genes and sensitivity of tumor radio-chemotherapy, 26 SNPs in 20 DNA repair genes were genotyped on 176 patients of NSCLC undertaking radio-chemotherapy treatment. In squamous cell carcinoma (SCC), as the rs2228000, rs2228001 (XPC),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chunbo, Nie, Huan, Li, Yiqun, Liu, Guiyou, Wang, Xu, Xing, Shijie, Zhang, Liping, Chen, Xin, Chen, Yue, Li, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887885/ https://www.ncbi.nlm.nih.gov/pubmed/27246533 http://dx.doi.org/10.1038/srep26526

Ejemplares similares

Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy
por: Wang, Chunbo, et al.
Publicado: (2020)

Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report
por: Zhao, Chunbo, et al.
Publicado: (2017)

Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
por: Wu, Chenglin, et al.
Publicado: (2022)

Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity
por: Gong, Yange, et al.
Publicado: (2023)

Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women
por: Van Dyke, Alison L., et al.
Publicado: (2009)

The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC
por: Peng, Qi, et al.
Publicado: (2021)

Post-operative radiotherapy in NSCLC.
por: Stewart, L., et al.
Publicado: (1997)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
por: Hao, Yanzhang, et al.
Publicado: (2014)

Editorial: The Role of DNA Repair Pathways in Resistance to Chemotherapy and Radiotherapy in Cancer
por: Lee, David Y., et al.
Publicado: (2022)

Radiotherapy fraction size sensitivity is modulated by DNA repair systems
por: Somaiah, N, et al.
Publicado: (2010)

The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways
por: Cáceres-Gutiérrez, Rodrigo E., et al.
Publicado: (2022)

Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer
por: Li, Xiong, et al.
Publicado: (2017)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells
por: Wu, Xiao, et al.
Publicado: (2017)

PI3K inhibition sensitizes EGFR wild-type NSCLC cell lines to erlotinib chemotherapy
por: Zhou, Xin, et al.
Publicado: (2021)

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
por: Gu, Weiguang, et al.
Publicado: (2023)

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC
por: Krug, David, et al.
Publicado: (2023)

Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC
por: Hu, Rong, et al.
Publicado: (2020)

Chemotherapy and quality of life in advanced NSCLC
por: Farrugia, D, et al.
Publicado: (2001)

Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC)
por: Trinidad López, Carmen, et al.
Publicado: (2019)

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
por: Chen, Pingyu, et al.
Publicado: (2022)

Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC
por: Su, Chunhong, et al.
Publicado: (2021)

Comparison of microsatellites, single-nucleotide polymorphisms (SNPs) and composite markers derived from SNPs in linkage analysis
por: Xing, Chao, et al.
Publicado: (2005)

Phosphorylation states of cell cycle and DNA repair proteins can be altered by the nsSNPs
por: Savas, Sevtap, et al.
Publicado: (2005)

Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes
por: Allen-Brady, Kristina, et al.
Publicado: (2005)

rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
por: Wang, Yong, et al.
Publicado: (2022)

De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity
por: Liu, Jingwei, et al.
Publicado: (2023)

Gross Tumor Volume Segmentation for Stage III NSCLC Radiotherapy Using 3D ResSE-Unet
por: Yu, Xinhao, et al.
Publicado: (2022)

Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC
por: Li, Yi, et al.
Publicado: (2015)

Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
por: Yang, Yudie, et al.
Publicado: (2022)

Chemotherapy and quality of life in advanced NSCLC – reply
por: Anderson, Heather, et al.
Publicado: (2001)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Wang, Hongyan, et al.
Publicado: (2018)

Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy
por: Yue, Xin, et al.
Publicado: (2023)

The efficacy of targeted therapy combined with radiotherapy and temozolomide-based chemotherapy in the treatment of glioma: A systemic review and meta-analysis of phase II/III randomized controlled trials
por: Ma, Yifan, et al.
Publicado: (2023)

Fasudil Increased the Sensitivity to Gefitinib in NSCLC by Decreasing Intracellular Lipid Accumulation
por: Liao, Tingting, et al.
Publicado: (2022)

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy
por: Chen, Mei, et al.
Publicado: (2022)

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

NPRL2 Sensitizes Human Non-Small Cell Lung Cancer (NSCLC) Cells to Cisplatin Treatment by Regulating Key Components in the DNA Repair Pathway
por: Jayachandran, Gitanjali, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8btk7gsvctdgetsifgla2mv5jc